PRKN and Parkinson disease: Most notably, Kano and colleagues showed lower proliferation of astrocytes in the human brain (lower GFAP protein levels) as well as in iPSC-derived midbrain organoids (lower GFAP and S100B protein levels) in PD cases caused by mutation in the PRKN gene62.